Monday, 11 June 2018
Dear Colleagues, Friends and Supporters of OIRF,
Welcome to the Volume 14, Final Issue #6 of “The Bridge” newsletter!
Welcome, but as you can see from my linked personal letter and announcement, also a fond farewell both to “The Bridge” and to OIRF. Although stressful and in many ways heartbreaking over the past few weeks, I finally feel comfortable that we have made the right decisions. Now, I am looking forward to the end of June and the end of this wonderful company that has been known as Occidental Institute for nearly 46 years.
OIRF represents not only the focus of my entire adult professional career, but also the dreams and vision of educating practitioners in the amazing field of Biological Medicine. I thank you for your support over the years and will look forward to hearing from you again in the future.
Here, however is Final Issue #6 of “The Bridge”. Ironically, as OIRF fades into history, this issue featured an article adapted from one of my recent lectures [now published as a separate report] entitled “The Past, Present and Future of Point and Medication Testing”. I find that practitioners first learning or even updating their skills with point testing too often get bogged down in the details. What point? Which meridian? Is the pressure exactly right? But I got a different reading when I retested it – Why???
As a bit of parting wisdom to all of you – relax a bit. Step back and take a look at the overall picture. Please remember that if you can understand and appreciate the underlying concepts and explanations, then the details and the manual testing technique will quickly fall into place.
I urge you to once again read over my article in the January 2018, Issue #1 regarding Resonance [now published as a separate report] to see a broader picture of the concept of not only point testing but also an overall explanation of Biological and BioResonance Therapies. Here then is my quite definitive historical article. I have tried to correct some of the myths and “stories” that are floating around out there about EAV and other point testing methods.
For example, there are a number of organizations out there talking about a Dr. Reinhard Voll who was a physician and an engineer. Well, no. Not quite. It’s Dr. Reinhold Voll who was a physician and worked with the engineer Fritz Werner to develop the earliest EAV devices. And so on. I had a lot of fun researching and presenting this lecture even though I have personally experienced many of the events since the beginning of OIRF in the summer of 1972. I trust you will find the information as interesting as I did.
With the note that OIRF has represented the Med-Tronik Company in Germany and their MORA products for over 40 years, we must advise that with the closing of OIRF we have also terminated all of our agreements with that company and rescinded our long standing recommendation for their products. Please see my “Policy Statement” in this regard.
And, a few closing words . . .
I trust you have found much of interest in these pages, but also in our many Issues over the years. Again, I offer my thanks for your support and I will be keeping a close eye on how this field is developing in the coming years. I wish you all auf Wiedersehen . . . until we meet again.
Carolyn
The Final Issue for OIRF Supporters
From THE BRIDGE Newsletter of OIRF
Published June 2018
© Copyright 2018, Occidental Institute, BC Canada
Monday, 11 June 2018
Dear Colleagues, Friends and Supporters of OIRF,
Welcome to the Volume 14, Final Issue #6 of “The Bridge” newsletter!
Welcome, but as you can see from my linked personal letter and announcement, also a fond farewell both to “The Bridge” and to OIRF. Although stressful and in many ways heartbreaking over the past few weeks, I finally feel comfortable that we have made the right decisions. Now, I am looking forward to the end of June and the end of this wonderful company that has been known as Occidental Institute for nearly 46 years.
OIRF represents not only the focus of my entire adult professional career, but also the dreams and vision of educating practitioners in the amazing field of Biological Medicine. I thank you for your support over the years and will look forward to hearing from you again in the future.
Here, however is Final Issue #6 of “The Bridge”. Ironically, as OIRF fades into history, this issue featured an article adapted from one of my recent lectures [now published as a separate report] entitled “The Past, Present and Future of Point and Medication Testing”. I find that practitioners first learning or even updating their skills with point testing too often get bogged down in the details. What point? Which meridian? Is the pressure exactly right? But I got a different reading when I retested it – Why???
As a bit of parting wisdom to all of you – relax a bit. Step back and take a look at the overall picture. Please remember that if you can understand and appreciate the underlying concepts and explanations, then the details and the manual testing technique will quickly fall into place.
I urge you to once again read over my article in the January 2018, Issue #1 regarding Resonance [now published as a separate report] to see a broader picture of the concept of not only point testing but also an overall explanation of Biological and BioResonance Therapies. Here then is my quite definitive historical article. I have tried to correct some of the myths and “stories” that are floating around out there about EAV and other point testing methods.
For example, there are a number of organizations out there talking about a Dr. Reinhard Voll who was a physician and an engineer. Well, no. Not quite. It’s Dr. Reinhold Voll who was a physician and worked with the engineer Fritz Werner to develop the earliest EAV devices. And so on. I had a lot of fun researching and presenting this lecture even though I have personally experienced many of the events since the beginning of OIRF in the summer of 1972. I trust you will find the information as interesting as I did.
With the note that OIRF has represented the Med-Tronik Company in Germany and their MORA products for over 40 years, we must advise that with the closing of OIRF we have also terminated all of our agreements with that company and rescinded our long standing recommendation for their products. Please see my “Policy Statement” in this regard.
And, a few closing words . . .
I trust you have found much of interest in these pages, but also in our many Issues over the years. Again, I offer my thanks for your support and I will be keeping a close eye on how this field is developing in the coming years. I wish you all auf Wiedersehen . . . until we meet again.
Carolyn
From THE BRIDGE Newsletter of OIRF
Published June 2018
© Copyright 2018, Occidental Institute, BC Canada
About the author
Carolyn L. Winsor
Carolyn’s decades-long involvement with the work of OIRF has given her the tools and skills to offer you unique and valuable insights into the ongoing developments in this always expanding field. Her Biological Medicine background includes:
Credentials
Featured News
Cancer is Your Messenger:
Early Warning Signs of Cancer Recently I got a telephone message complaint from my patient’s friend. Apparently, I missed the diagnosis of cancer with [...]
Tainted Evidence
Director’s Note: I have blatantly borrowed (verbatim) the following commentary out of IMCJ without permission and all credit goes directly to Dr. Benda and [...]
The Bridge, February 2008, Part 2
Here is a sample of The Bridge Newsletter as it appeared in 2008. This Part 2 Supplement to the February Issue introduced a number [...]
Instrumentation Issues, Changes and Pricing
I wanted to start off this “commercial” portion of the September newsletters with some personal comments. You can see from the history of OIRF [...]
Sign-up to receive updates sent straight to your inbox